Scientific work

Prof. Dr. Fatih Teker

95 publications. The source of the information is stated next to each publication.

Back to profile

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex

  2. Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye

    Current Oncology, 2026

    DOI 10.3390/curroncol33030155 PMID 41892183 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  3. Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.96266 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study—Real-world data.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e20006 Open-access full textSource: OpenAlex

  5. Assessment of the Clinicopathologic Characteristics and Survival Rates of Colorectal Cancer Among Syrian Refugees and Turkish Population in Gaziantep Province

    JCO Global Oncology, 2024

    DOI 10.1200/go.24.00211 PMID 39509657 Open-access full textSource: OpenAlex

  6. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1287 PMID 37133230 22 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

    Bosnian Journal of Basic Medical Sciences, 2022

    DOI 10.17305/bjbms.2021.7069 PMID 35460397 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

    Future Oncology, 2022

    DOI 10.2217/fon-2021-1248 PMID 35081732 27 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement

    Molecular Imaging and Biology, 2022

    DOI 10.1007/s11307-022-01729-x PMID 35411447 35 citations (Europe PMC) Source: OpenAlex

  11. Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer

    International Journal of Gynecological Cancer, 2022

    DOI 10.1136/ijgc-2021-003165 PMID 35086927 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  12. Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer

    Annals of Nuclear Medicine, 2021

    DOI 10.1007/s12149-021-01672-x PMID 34436740 86 citations (Europe PMC) Source: OpenAlex

  13. Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving 177Lu-DOTATATE therapy?

    PubMed, 2021

    DOI 10.1967/s002449912352 PMID 34352047 9 citations (Europe PMC) Source: OpenAlex

  14. Covid Sekeller

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.121 Source: OpenAlex

  15. Vismodegib for Patients with Advanced Basal Cell Carcinoma: One Center’s Experience

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2019-71992 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. A rare case of gastric metastastasis from lung cancer

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30420-5 Source: OpenAlex

  17. Characteristics of the Patients Undergoing Colonoscopy in a Single Center within an 8-year Period

    Journal of Gastrointestinal & Digestive System, 2017

    DOI 10.4172/2161-069x.1000503 Source: OpenAlex

  18. The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG).

    PubMed, 2016

    PMID 27685904 20 citations (Europe PMC) Source: OpenAlex

  19. The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours

    Journal of International Medical Research, 2016

    DOI 10.1177/0300060516638992 PMID 27048386 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  20. Effect of body mass index on chemotherapy-induced neutropenia in breast cancer.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e18218 Source: OpenAlex

  21. Quality of life in colorectal cancer patients during chemotherapy in the era of monoclonal antibody therapies.

    PubMed, 2015

    PMID 26011334 11 citations (Europe PMC) Source: OpenAlex

  22. PRIMARY TESTICULAR LYMPHOMA: A SINGLE CENTRE EXPERIENCE

    Experimental Oncology, 2015

    DOI 10.31768/2312-8852.2015.37(3):223-226 PMID 26422109 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  23. A case of gastric cancer with liver metastases had a complete response with cisplatin and capecitabine as third-line chemotherapy

    Journal of Cancer Research and Therapeutics, 2015

    DOI 10.4103/0973-1482.150348 PMID 26881594 1 citation (Europe PMC) Source: OpenAlex

  24. A Case of Deep Vein Thrombosis in the Postpartum Period

    Journal of Academic Research in Medicine, 2015

    DOI 10.5152/jarem.2015.568 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  25. HIGH BODY-MASS INDEX IS NOT ASSOCIATED WITH WORSE CLINICOPATHOLOGICAL CHARACTERISTICS IN PREDOMINANTLY OBESE BREAST CANCER PATIENTS

    Experimental Oncology, 2015

    DOI 10.31768/2312-8852.2015.37(4):281-284 PMID 26710841 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  26. Quality of life assesment in patients with non-small cell lung cancer patients who have or have not received second line chemotherapy

    Acta Oncologica Turcica, 2015

    DOI 10.5505/aot.2015.18189 Source: OpenAlex

  27. İkinci basamak kemoterapi alan veya almayan ileri evre küçük hücreli dışı akciğer kanserli hastalarda yaşam kalitesi değerlendirilmesi

    DergiPark (Istanbul University), 2015

    Source: OpenAlex

  28. Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.6.2651 PMID 24761879 81 citations (Europe PMC) Source: OpenAlex

  29. The value of red blood cell distribution width in endometrial cancer

    Clinical Chemistry and Laboratory Medicine (CCLM), 2014

    DOI 10.1515/cclm-2014-0699 PMID 25860865 40 citations (Europe PMC) Source: OpenAlex

  30. Efficacy and Safety of Docetaxel or Epirubicin, Combined with Cisplatin and Fluorouracil, (DCF and ECF) Regimens as First Line Chemotherapy for Advanced Gastric Cancer: a Retrospective Analysis from Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.16.6727 PMID 25169516 8 citations (Europe PMC) Source: OpenAlex

  31. Single dose regorafenib-induced hypertensive crisis.

    PubMed, 2014

    PMID 24980770 3 citations (Europe PMC) Source: OpenAlex

  32. Be careful before prescribing warfarin and octreotide together: a new drug-drug interaction report.

    PubMed Central, 2014

    PMID 26052213 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  33. Breast cancer in the elderly.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e11506 Source: OpenAlex

  34. Brain Metastases in Gastrointestinal Cancers

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(20)33134-3 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  35. Baseline lymphopenia as a prognostic marker for colorectal carcinoma.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.e14107 1 citation (OpenAlex) Source: OpenAlex

  36. Real World Effectiveness Data and Safety in Patients Receiving Pazopanib with Advanced or Metastatic Renal Cell Carcinoma (PRINCIPAL) 2015

    Source: livhospital.com profile page

  37. Regorafenib in Subjects with Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy (REGARD) 2019

    Source: livhospital.com profile page

  38. A Multicenter, Randomized, Double-blind, Phase III Study of BAT1706 versus EU-Avastin® plus Chemotherapy in Patients with Advanced Non - squamous Non-Small Cell Lung Cancer. 2019

    Source: livhospital.com profile page

  39. FIGHT: A Phase 3 Randomized, Double-Blind, Controlled Study Evaluating FPA144 and Modified FOLFOX6 in Patients with Previously Untreated Advanced Gastric and Gastroesophageal Cancer: Phase 3 Preceded by Dose Finding in Phase 1A 2019.

    Source: livhospital.com profile page

  40. A Randomized, Open-Label, International, Multi- Center, Phase 3 Clinical Study of PD-1 Antibody SHR-1210 Plus Apatinib (Rivoceranib) Mesylate Versus Sorafenib as First-Line Therapy in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Therapy.

    Source: livhospital.com profile page

  41. Platinum-Based Chemotherapy with/without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer (POD1UM-304)

    Source: livhospital.com profile page

  42. Karacin C, Oksuzoglu B, Demirci A, Keskinkılıç M, Baytemür NK, Yılmaz F, Selvi O, Erdem D, Avşar E, Paksoy N, Demir N, Göksu SS, Türker S, Bayram E, Çelebi A, Yılmaz H, Kuzu ÖF, Kahraman S, Gökmen İ, Sakin A, Alkan A, Nayır E, Uğraklı M, Acar Ö, Ertürk İ, Demir H, Aslan F, Sönmez Ö, Korkmaz T, Celayir ÖM, Karadağ İ, Kayıkçıoğlu E, Şakalar T, Öktem İN, Eren T, Erul E, Mocan EE, Kalkan Z, Yıldırım N, Ergün Y, Akagündüz B, Karakaya S, Kut E, Teker F, Demirel BÇ, Karaboyun K, Almuradova E, Ünal OÜ, Oyman A, Işık D, Okutur K, Öztosun B, Gülbağcı BB, Kalender ME, Şahin E, Seyyar M, Özdemir Ö, Selçukbiricik F, Kanıtez M, Dede İ, Gümüş M, Gökmen E, Yaren A, Menekşe S, Ebinç S, Aksoy S, İmamoğlu Gİ, Altınbaş M, Çetin B, Uluç BO, Er Ö, Karadurmuş N, Erdoğan AP, Artaç M, Tanrıverdi Ö, Çiçin İ, Şendur MAN, Oktay E, Bayoğlu İV, Paydaş S, Aydıner A, Salim DK, Geredeli Ç, Yavuzşen T, Doğan M, Hacıbekiroğlu İ. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer w

    Source: livhospital.com profile page

  43. Teker F, Kemal Y, Yilmaz B, Ekinci AS, Güney Y, Bek Y, Turgut M, Yücel I. '' RDW is a novel prognostic parameter in diffuse large B cell lymphoma in the Rituximab era ''. JJ Biomark. 2015, 1(2):009.

    Source: livhospital.com profile page

  44. Nurettin Suna, Bülent Yalçın, Ahmet Şiar Ekinci, Onur Aydınlı, Ahmet Demirkazık, İsmail Savaş, Nurullah Zengin, Zeynep Bıyıklı, Fatih Teker, Haliz Yerlikaya, Fikri İçli. İkinci Basamak kemoterapi alan veya alamayan ileri evre küçük hücreli dışı akciğer kanserli hastalarda yaşam kalitesi değerlendirilmesi. AOT 2015. 18189 53-62.

    Source: livhospital.com profile page

  45. Hande Atalay, Banu Boyuk, Muhammed Ateş, Aslan Çelebi, Ismail Ekizoğlu, Didik Arzu, Teker Fatih, Igdem Ayşenur. Idiopathic Intrahepatic Cholestasis; An Unusual Presentation Of Hodgkin’s Disease. (2015) 24 th Conference Of Asian-Pacific Association For The Study Of The Liver (Poster)

    Source: livhospital.com profile page

  46. Bahiddin Yilmaz, Dilek Erdem, Fatih Teker, Ibrahim Goren, Beytullah Yildirim, Engin Kut, Derya Sarikaya, Idris Yucel. The Effect of Anticancer Therapy on Anti-HBS in Patients with Hematological Malignancies and Solid Tumors (2015) 4 th Mediterranean Multidiciplinary Oncology Forum

    Source: livhospital.com profile page

  47. Erdem Dilek, Yilmaz Bahiddin, Fatih Çilingir, Kocasaraç Selim, Teker Fatih, Demirağ Güzin, Yücel Idris. Breast Cancer In Elderly. 2013 Asco Annual Meeting (Poster)

    Source: livhospital.com profile page

  48. Karadağ Berrin, Teker Fatih, Sema Uçak, Hikmet Bayer, Nazif Bağriaçik, Ali Ipbüker, Yüksel Altintaş. Relationship Of Pro-Bnp And Microalbuminuria In Diabetic Patients. 8th Congress Of The European Federation Of Internal Medicine (Poster)

    Source: livhospital.com profile page

  49. Karadağ Berrin,Teker Fatih,Sema Uçak,Hikmet Bayer,Nazif Bağriaçik,Ali Ipbüker, Yüksel Altuntaş Are Pro-Bnp Levels Different In Diabetic And Nondiabetic Patients? 8th Congress Of The European Federation Of Internal Medicine (Poster)

    Source: livhospital.com profile page

  50. Teker Fatih (2019), Merkezi Sinir Sistemi Metastazlarına Yaklaşım. 5. Karadeniz Meme Kongresi

    Source: livhospital.com profile page